Market Tracker

04/23 12:03pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

6.11
Real-Time Quote
 -0.09 / -1.45%
Today’s Change
1.65
Today|||52-Week Range
8.44
+30.00%
Year-to-Date

Today’s Trading

Previous close6.20
Today’s open6.07
Day’s range6.07 - 6.16
Volume15,830
Average volume (3 months)290,940
Market cap$254.3M
Dividend yield--
Data as of 11:48am ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-157.14%
Earnings growth (this year)+44.76%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales79.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...-0.18-0.92%
GLYCGlycoMimetics Inc-0.07-0.50%
XNPTXenoport Inc-0.38-7.74%
NAVBNavidea Biopharmaceu...-0.03-1.71%
Data as of 12:02pm ET, 04/23/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$1.9M
Annual profit (last year)-$51.2M
Net profit margin-2,733.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts